Amgen to invest $100 million in SoftBank-backed Neumora
2 min read
Neumora said Amgen's investment, along with $400 million it had raised from other investors including SoftBank Vision Fund, will help it bring precision...
(Reuters) - U.S. biotech Amgen Inc has made a $100-million equity investment in Neumora Therapeutics, the brain disease drug developer said on Thursday, adding that it will also get global rights to develop and sell certain of Amgen's experimental drugs for neurodegenerative diseases.

medicines – already used in the field of cancer treatments – for complex brain diseases.

"Traditional neuroscience R&D is constrained by a…
Read full article